Get the Stockscreener App
148.10
2.29%
-3.47
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Cardinal Health Inc stock is traded at $148.10, with a volume of 2.65M.
It is down -2.29% in the last 24 hours and down -5.73% over the past month.
Cardinal Health is one of three leading pharmaceutical wholesalers in the US, engaged in sourcing and distributing of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. Cardinal, Cencora, and McKesson hold well over 90% of the US pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.
See More
Previous Close:
$151.57
Open:
$151.84
24h Volume:
2.65M
Relative Volume:
1.24
Market Cap:
$35.37B
Revenue:
$222.58B
Net Income/Loss:
$1.57B
P/E Ratio:
22.96
EPS:
6.45
Net Cash Flow:
$1.85B
1W Performance:
-1.01%
1M Performance:
-5.73%
6M Performance:
+16.56%
1Y Performance:
+34.11%
1-Day Range:
$147.21
$152.75
1-Week Range:
$147.21
$153.70
52-Week Range:
$106.54
$168.44
Cardinal Health Inc Stock (CAH) Company Profile
Name
Cardinal Health Inc
Sector
Industry
Phone
(614) 757-3033
Address
7000 CARDINAL PLACE, DUBLIN, OH
Compare CAH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CAH
Cardinal Health Inc
|
148.10 | 35.75B | 222.58B | 1.57B | 1.85B | 6.45 |
|
MCK
Mckesson Corporation
|
689.45 | 83.49B | 377.60B | 3.35B | 5.67B | 25.08 |
|
COR
Cencora Inc
|
292.60 | 56.29B | 316.65B | 1.91B | 1.14B | 9.72 |
|
HSIC
Henry Schein Inc
|
69.60 | 8.15B | 12.50B | 314.00M | 421.00M | 2.44 |
|
AHG
Akso Health Group Adr
|
1.77 | 701.93M | 2.22M | -5.63M | -1.68M | -0.24 |
Cardinal Health Inc Stock (CAH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-03-25 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Feb-05-25 | Upgrade | Jefferies | Hold → Buy |
| Jan-08-25 | Upgrade | TD Cowen | Hold → Buy |
| Jan-07-25 | Upgrade | Evercore ISI | In-line → Outperform |
| Jan-06-25 | Upgrade | BofA Securities | Neutral → Buy |
| Dec-13-24 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Dec-04-24 | Resumed | Mizuho | Outperform |
| Feb-26-24 | Initiated | Leerink Partners | Outperform |
| Feb-09-24 | Upgrade | Argus | Hold → Buy |
| Jan-03-24 | Initiated | Barclays | Overweight |
| Dec-14-23 | Initiated | Wells Fargo | Underweight |
| Jul-10-23 | Downgrade | Evercore ISI | Outperform → In-line |
| Mar-31-23 | Initiated | Citigroup | Neutral |
| Feb-03-23 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Nov-04-22 | Upgrade | BofA Securities | Underperform → Neutral |
| Aug-22-22 | Resumed | Morgan Stanley | Overweight |
| May-26-22 | Downgrade | Barclays | Overweight → Equal Weight |
| May-18-22 | Upgrade | Evercore ISI | In-line → Outperform |
| Apr-12-22 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Apr-01-22 | Resumed | Credit Suisse | Neutral |
| Aug-06-21 | Downgrade | Deutsche Bank | Buy → Hold |
| Aug-05-21 | Downgrade | BofA Securities | Buy → Underperform |
| May-10-21 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Jan-08-21 | Upgrade | Wolfe Research | Underperform → Peer Perform |
| Nov-02-20 | Upgrade | Barclays | Equal Weight → Overweight |
| Sep-25-20 | Upgrade | Deutsche Bank | Hold → Buy |
| Jul-20-20 | Upgrade | Guggenheim | Neutral → Buy |
| May-15-20 | Upgrade | UBS | Neutral → Buy |
| Apr-23-20 | Resumed | Credit Suisse | Neutral |
| Mar-20-20 | Upgrade | BofA/Merrill | Underperform → Buy |
| Feb-12-20 | Upgrade | Morgan Stanley | Underweight → Equal-Weight |
| Feb-07-20 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Dec-16-19 | Downgrade | Guggenheim | Buy → Neutral |
| Sep-12-19 | Initiated | Deutsche Bank | Hold |
| Aug-27-19 | Downgrade | Argus | Buy → Hold |
| Aug-20-19 | Upgrade | Guggenheim | Neutral → Buy |
| Apr-18-19 | Initiated | Guggenheim | Neutral |
| Jan-17-19 | Initiated | UBS | Neutral |
| Nov-16-18 | Downgrade | Leerink Partners | Outperform → Mkt Perform |
| Apr-24-18 | Upgrade | Leerink Partners | Mkt Perform → Outperform |
| Apr-02-18 | Upgrade | Argus | Hold → Buy |
| Mar-08-18 | Initiated | Barclays | Equal Weight |
| Feb-27-18 | Resumed | BofA/Merrill | Underperform |
| Jan-05-18 | Initiated | Evercore ISI | In-line |
View All
Cardinal Health Inc Stock (CAH) Latest News
Cardinal Health's Insider Share Sales Amid Strategic Growth Moves and Earnings Optimism - AInvest
Cardinal Health's Insider Selling: Signal of Distress or Strategic Opportunity? - AInvest
Cardinal Health Inc. stock outperforms competitors on strong trading day - MarketWatch
Stock Analysis | Cardinal Health OutlookBullish Technicals Meet Mixed News and Strong Fundamentals - AInvest
Nuclear Medicine Market is expected to generate a revenue of USD 12.99 Billion by 2032, Globally, at 9.30% CAGR: Verified Market Research® - GlobeNewswire Inc.
Those Who Invested in Cardinal Health (NYSE:CAH) Five Years Ago Are up 237% - 富途牛牛
How Cardinal Health Inc. (CAH) Affects Rotational Strategy Timing - news.stocktradersdaily.com
Cardinal Health Shares Sink on Mixed Results, $1.9 Billion Solaris Health Deal - MSN
Zacks.com featured highlights AGCO, Vertiv Holdings, TE Connectivity, Cardinal Health and Woodward - Yahoo Finance
How to forecast Cardinal Health Inc. trends using time series2025 Market Outlook & Growth Focused Investment Plans - Newser
How to monitor Cardinal Health Inc. with trend dashboards2025 Market Overview & Fast Moving Trade Plans - Newser
Cardinal Health’s Ola Snow sells $4.19 million in shares - Investing.com
Cardinal Health CAO Mayer sells $5.6m in shares - Investing.com
Cardinal Health CAO Scherer sells $1m in shares - Investing.com
Cardinal Health CEO Mason sells $6.1m in shares - Investing.com
Is Cardinal Health Inc. meeting your algorithmic filter criteriaJuly 2025 Momentum & Daily Chart Pattern Signals - Newser
Cardinal Health Q2 Earnings Call: Analyst Questions and Concerns - AInvest
5 Must-Read Analyst Questions From Cardinal Health’s Q2 Earnings Call - TradingView
Should Value Investors Buy Cardinal Health (CAH) Stock? - ca.finance.yahoo.com
Precision Trading with Cardinal Health Inc. (CAH) Risk Zones - news.stocktradersdaily.com
Cardinal Health raises fiscal 2026 EPS guidance to $9.30-$9.50 while advancing specialty platform through Solaris Health acquisition - MSN
Short Term Charts Align With Long Term Uptrend in Cardinal Health Inc.July 2025 Summary & Verified High Yield Trade Plans - newsyoung.net
Cardinal Health: A Resilient Healthcare Play in a Fragmented Landscape - AInvest
Cardinal Health (CAH) Confirms US$0.51 Dividend Payout for October 2025 - simplywall.st
Cardinal Health declares $0.5107 dividend - MSN
Cardinal Health's $2.4B Solaris Acquisition Drives Urology Expansion Despite $390M Volume Ranking 265th - AInvest
Assessing Cardinal Health's Dividend Strategy in Light of Its Strong Financial Momentum and Strategic Growth Initiatives - AInvest
Cardinal Health board approves quarterly dividend of $0.5107 per share By Investing.com - Investing.com Canada
Cardinal Health Keeps Quarterly Dividend at $0.5107 per Share, Payable Oct. 15 to Holders of Record on Oct. 1 - MarketScreener
Cardinal Health Board of Directors Approves Quarterly Dividend - MarketScreener
$0.51 Per Share: Cardinal Health Maintains Steady Quarterly Dividend Payout for Shareholders - Stock Titan
Cardinal Health (CAH) Falls on Dismal Revenue Performance - msn.com
Cardinal Health, Inc. (CAH)’s CEO Is So Good, The Recent Earnings Surprised Me, Says Jim Cramer - Yahoo Finance
Cardinal Health to Acquire Solaris Health for Urology Expansion - sharewise.com
Cardinal Health will bet on scale, compliance to lead in bid process for CGMs - HME News
Lee Equity to sell urology platform for $1.9bn to Cardinal Health; Bain, Arlington, Revelstoke invest in immunotherapy; H1 healthcare deals that mattered - pehub.com
Cardinal Health (CAH) Announces $1 Billion Debt Offering - GuruFocus
Cardinal Health announces $1 billion notes offering in two tranches By Investing.com - Investing.com Australia
Cardinal Health announces $1 billion notes offering in two tranches - Investing.com
Cardinal Health to Acquire UroGen Pharma for $1.9 Billion, Valuing Company at $16 Per Share - AInvest
Cardinal Health Board Of Directors Approves Quarterly Dividend - Barchart.com
Cardinal Health Posts Higher Profit, Enters $1.9 Billion Solaris Health Buy - MSN
Cardinal Health Sells Bonds To Back Solaris Health Deal - Finimize
Cardinal Health's $1.9 Billion Urology Bet Sends Shares Sliding -- But Could Spark Long-Term Growth - Yahoo Finance
Citi Remains a Hold on Cardinal Health (CAH) - The Globe and Mail
Cardinal Health (CAH) Is Down 5.4% After Net Income Doubles Despite Lower Sales – Has Profitability Turned the Tide? - simplywall.st
Cardinal Health Rises 1.24% Despite Diving Trading Volume to $510M 234th in Market Activity - AInvest
Cardinal Health Raises Earnings Outlook, Acquires Solaris Health for $1.9 Billion - AInvest
Cardinal Health Sells $1 Billion of Bonds for Solaris Deal - Yahoo Finance
Cardinal Health prices US$1bn bond to fund Solaris deal - IFR Asia
Health Care Stocks Climb As Deals And Results Grab Attention - Finimize
Cardinal Health Inc Stock (CAH) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.51%
2.04%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):